- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01799031
Educational Intervention for Reducing Work Disability in Breast Cancer Survivors
Reducing Work Disability in Breast Cancer Survivors
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
PRIMARY OBJECTIVES:
I. Determine the feasibility and usability of the Work Ability Improvement Through Symptom Management and Ergonomic Strategies (WISE) and empirically evaluate its effect on short-term work ability among breast cancer survivors (BCS).
SECONDARY OBJECTIVES:
I. Explore individual and workplace factors associated with work ability in BCS.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM I: Patients receive access to the WISE web-based educational intervention to help BCS manage their symptoms, identify ergonomic workplace problems and risks, and implement ergonomic modifications. Patients also receive standard of care comprising symptom management therapies and a pamphlet on employment rights.
ARM II: Patients receive standard of care comprising symptom management therapies and a pamphlet on employment rights.
After completion of study treatment, patients are followed up at 3 and 6 months.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Wisconsin
-
Madison, Wisconsin, Forenede Stater, 53792
- University of Wisconsin Hospital and Clinics
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Diagnosed with breast cancer
- Employed at time of cancer diagnosis (defined as paid employment > 20 hours/week)
- Within six months of completion of active treatment
- Working during treatment or intending to return to work following active treatment
- Computer and internet access
Exclusion Criteria:
- Patients who do not intend to continue/resume working following treatment
- Develop distant metastases or progressive disease
- Prior diagnosis of malignancy at any other site except for in situ carcinomas of the cervix or non-melanomatous skin cancers
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Arm I (WISE)
Patients receive access to the WISE web-based educational intervention to help BCS manage their symptoms, identify ergonomic workplace problems and risks, and implement ergonomic modifications.
Patients also receive standard of care comprising symptom management therapies and a pamphlet on employment rights.
|
Hjælpestudier
Hjælpestudier
Andre navne:
Receive access to the WISE web-based educational intervention
Receive standard of care
Andre navne:
Receive access to the WISE web-based educational intervention
Andre navne:
|
|
Aktiv komparator: Arm II (control)
Patients receive standard of care comprising symptom management therapies and a pamphlet on employment rights.
|
Hjælpestudier
Hjælpestudier
Andre navne:
Receive standard of care
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Usability of the WISE website as assessed by responses to a 5-point Likert scale
Tidsramme: 3 months
|
The primary analysis of the effect of the WISE intervention on work ability will be performed using a Wilcoxon rank sum test.
|
3 months
|
|
Usability of the WISE website as assessed by responses to a 5-point Likert scale
Tidsramme: 6 months
|
The primary analysis of the effect of the WISE intervention on work ability will be performed using a Wilcoxon rank sum test.
|
6 months
|
|
Work ability, assessed by the Work Limitations Questionnaire (WLQ)
Tidsramme: Baseline
|
Baseline
|
|
|
Work ability, assessed by the WLQ
Tidsramme: 3 months
|
3 months
|
|
|
Work ability, assessed by the WLQ
Tidsramme: 6 months
|
6 months
|
|
|
Individual factors, including symptoms assessed using the Symptom Bother-Revised scale (SB-R) and MD Anderson Symptom Inventory (MDASI), socio-demographic factors, individual disease factors, and treatment factors
Tidsramme: Baseline
|
Baseline
|
|
|
Individual factors, including symptoms assessed using the SB-R and MDASI, socio-demographic factors, individual disease factors, and treatment factors
Tidsramme: 3 months
|
3 months
|
|
|
Individual factors, including symptoms assessed using the SB-R and MDASI, socio-demographic factors, individual disease factors, and treatment factors
Tidsramme: 6 months
|
6 months
|
|
|
Workplace factors, including work history, job characteristics, job control, job support, and level of job stress using the Job Content Questionnaire (JCQ)
Tidsramme: Baseline
|
Baseline
|
|
|
Workplace factors, including work history, job characteristics, job control, job support, and level of job stress using the JCQ
Tidsramme: 3 months
|
3 months
|
|
|
Workplace factors, including work history, job characteristics, job control, job support, and level of job stress using the JCQ
Tidsramme: 6 months
|
6 months
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Feasibility measures, including participation/dropout rates, patient satisfaction, usability/satisfaction with WISE, knowledge/use of self-care symptom management/ergonomic strategies, and use of ergonomic/symptom management strategies, and barriers
Tidsramme: Up to 6 months
|
Up to 6 months
|
|
Self-car symptom management strategies used (if any), workplace strategies implemented, and barriers to implementation
Tidsramme: Up to 6 months
|
Up to 6 months
|
|
Individuals self-reported work ability, using the Work Ability Index (WAI)
Tidsramme: Up to 6 months
|
Up to 6 months
|
|
Employment status
Tidsramme: Up to 6 months
|
Up to 6 months
|
|
Change in job performance or difficulty performing work tasks
Tidsramme: Baseline to 6 months
|
Baseline to 6 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Mary Sesto, University of Wisconsin, Madison
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- OS12115
- A536130 (Anden identifikator: UW Madison)
- NCI-2012-03055 (Registry Identifier: NCI Trial ID)
- 2012-0729 (Anden identifikator: Institutional Review Board)
- SMPH\ORTHOPEDIC&REHAB\PT (Anden identifikator: UW Madison)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Brystkræft
-
Cairo UniversityIkke rekrutterer endnu
-
The First Affiliated Hospital of Xiamen UniversityIkke rekrutterer endnuLocally Advanced Breast Cancer (LABC)
-
Abouqir General HospitalAlexandria UniversityRekrutteringBreast Udseende Rekonstruktion DisproportionEgypten
-
Beijing Bio-Targeting Therapeutics Technology Co...Trukket tilbage
-
Indonesia UniversityIkke rekrutterer endnuPræhabilitering | Postoperativ inflammation | Locally Advanced Breast Cancer (LABC)Indonesien
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital og andre samarbejdspartnereAfsluttetDen kliniske anvendelsesvejledning af Conebeam Breast CTKina
-
Atlas UniversityIkke rekrutterer endnuBrystkræft | Locally Advanced Breast Cancer (LABC)Tyrkiet (Türkiye)
-
ETOP IBCSG Partners FoundationAfsluttetBreast Cancer Invasive NosItalien
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; Roche Farma, S.AAfsluttetBreast Cancer Invasive NosSpanien
-
Second Affiliated Hospital, School of Medicine,...RekrutteringTNBC, Triple Negative Breast CancerKina
Kliniske forsøg med spørgeskemaadministration
-
Academisch Medisch Centrum - Universiteit van Amsterdam...AfsluttetAnalgesi | Akutte smerter på grund af traumerHolland
-
Universitas Sumatera UtaraAfsluttetTilstand / Fokus: Postoperativ kognitiv dysfunktion (POCD) efter rygsøjleoperationIndonesien
-
Camilo Jose Cela UniversityAfsluttet
-
VivatechAfsluttet
-
Laekna LimitedRekrutteringOvervægtige og fede frivilligeKina
-
University of CalgaryIkke rekrutterer endnuKoronararteriesygdom | Hjertefejl | Diabetes mellitus | Kroniske lungesygdomme | Nyre sygdomCanada
-
Catholic University of the Sacred HeartAfsluttetLivskvalitet | Kirurgisk sår | Biopsi sår | Heling af kirurgiske sårItalien
-
MWolztUkendt
-
J2H BiotechAfsluttetIkke-alkoholisk SteatohepatitisSydkorea
-
John Paul II Hospital, KrakowNational Center for Research and Development, Poland; KCRIAfsluttet